Genetic Variant May Protect Against IBD, Could Be Target for New Therapies

Genetic Variant May Protect Against IBD, Could Be Target for New Therapies
People who have a particular variant of a gene called TYK2 are naturally protected against autoimmune diseases such as inflammatory bowl disease (IBD) according to a study published in the leading scientific journal Science Translational Medicine. This finding suggests that drugs that target the TYK2 gene or mimic the protective effect of the TYK2 genetic variant could be developed to treat IBD as well as other autoimmune diseases.

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *